{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:28:38Z","timestamp":1772148518034,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["SFB-TR84 Z01b"],"award-info":[{"award-number":["SFB-TR84 Z01b"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["SFB-TR84 C6, C9"],"award-info":[{"award-number":["SFB-TR84 C6, C9"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"German Federal Ministry of Education and Research German Ministry of Education","award":["CAPSyS (01ZX1304B)"],"award-info":[{"award-number":["CAPSyS (01ZX1304B)"]}]},{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Community acquired pneumonia, mainly caused by <jats:italic>Streptococcus pneumoniae<\/jats:italic> (<jats:italic>S.pn.),<\/jats:italic> is a common cause of death worldwide. Despite adequate antibiotic therapy, pneumococcal pneumonia can induce pulmonary endothelial hyperpermeability leading to acute lung injury, which often requires mechanical ventilation (MV) causing ventilator-induced lung injury (VILI). Endothelial stabilization is mediated by angiopoietin-1 induced Tie2 activation. PEGylated (polyethylene glycol) Tie2-agonist Vasculotide (VT) mimics Angiopietin-1 effects. Recently, VT has been shown to reduce pulmonary hyperpermeability in murine pneumococcal pneumonia. The aim of this study was to determine whether VT reduces lung damage in <jats:italic>S.pn.<\/jats:italic> infected and mechanically ventilated mice. Pulmonary hyperpermeability, immune response and bacterial load were quantified in <jats:italic>S.pn.<\/jats:italic> infected mice treated with Ampicillin\u2009+\u2009\/\u2212VT and undergoing six hours of MV 24\u00a0h post infection. Histopathological lung changes, Tie2-expression and -phosphorylation were evaluated. VT did not alter immune response or bacterial burden, but interestingly combination treatment with ampicillin significantly reduced pulmonary hyperpermeability, histological lung damage and edema formation. Tie2-mRNA expression was reduced by <jats:italic>S.pn.<\/jats:italic> infection and\/or MV but not restored by VT. Moreover, Tie2 phosphorylation was not affected by VT. These findings indicate that VT may be a promising adjunctive treatment option for prevention of VILI in severe pneumococcal pneumonia.<\/jats:p>","DOI":"10.1038\/s41598-022-19560-3","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T17:03:55Z","timestamp":1663261435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Adjunctive therapy with the Tie2 agonist Vasculotide reduces pulmonary permeability in Streptococcus pneumoniae infected and mechanically ventilated mice"],"prefix":"10.1038","volume":"12","author":[{"given":"Aina","family":"Lask","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgitt","family":"Gutbier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Kershaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geraldine","family":"Nouailles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achim D.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger C.","family":"M\u00fcller-Redetzky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Chackowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas A.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Van Slyke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Witzenrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,15]]},"reference":[{"key":"19560_CR1","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1164\/rccm.201501-0140OC","volume":"192","author":"DT Eurich","year":"2015","unstructured":"Eurich, D. T., Marrie, T. J., Minhas-Sandhu, J. K. & Majumdar, S. R. Ten-year mortality after community-acquired pneumonia. A prospective cohort. Am. J. Respir. Crit. Care Med. 192, 597\u2013604. https:\/\/doi.org\/10.1164\/rccm.201501-0140OC (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"19560_CR2","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.12688\/f1000research.9283.1","volume":"5","author":"C Feldman","year":"2016","unstructured":"Feldman, C. & Anderson, R. Epidemiology, virulence factors and management of the pneumococcus. F1000 Res. 5, 2320 (2016).","journal-title":"F1000 Res."},{"key":"19560_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1378\/chest.15-0484","volume":"148","author":"C Feldman","year":"2015","unstructured":"Feldman, C. & Anderson, R. Community-acquired pneumonia: Pathogenesis of acute cardiac events and potential adjunctive therapies. Chest 148, 523\u2013532. https:\/\/doi.org\/10.1378\/chest.15-0484 (2015).","journal-title":"Chest"},{"key":"19560_CR4","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/thx.2008.109785","volume":"64","author":"S Ewig","year":"2009","unstructured":"Ewig, S. et al. New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 64, 1062\u20131069. https:\/\/doi.org\/10.1136\/thx.2008.109785 (2009).","journal-title":"Thorax"},{"key":"19560_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S1359-6101(03)00059-5","volume":"14","author":"RB Goodman","year":"2003","unstructured":"Goodman, R. B., Pugin, J., Lee, J. S. & Matthay, M. A. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev. 14, 523\u2013535 (2003).","journal-title":"Cytokine Growth Factor Rev."},{"key":"19560_CR6","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1097\/01.CCM.0000220496.48295.A9","volume":"34","author":"M Witzenrath","year":"2006","unstructured":"Witzenrath, M. et al. Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia. Crit. Care Med. 34, 1947\u20131954. https:\/\/doi.org\/10.1097\/01.CCM.0000220496.48295.A9 (2006).","journal-title":"Crit. Care Med."},{"key":"19560_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa032193","volume":"351","author":"RG Brower","year":"2004","unstructured":"Brower, R. G. et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N. Engl. J. Med. 351, 327\u2013336. https:\/\/doi.org\/10.1056\/NEJMoa032193 (2004).","journal-title":"N. Engl. J. Med."},{"key":"19560_CR8","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1056\/NEJMoa062200","volume":"354","author":"L National Heart","year":"2006","unstructured":"National Heart, L. et al. Comparison of two fluid-management strategies in acute lung injury. N. Engl. J. Med. 354, 2564\u20132575. https:\/\/doi.org\/10.1056\/NEJMoa062200 (2006).","journal-title":"N. Engl. J. Med."},{"key":"19560_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(67)90168-7","volume":"2","author":"DG Ashbaugh","year":"1967","unstructured":"Ashbaugh, D. G., Bigelow, D. B., Petty, T. L. & Levine, B. E. Acute respiratory distress in adults. Lancet 2, 319\u2013323 (1967).","journal-title":"Lancet"},{"key":"19560_CR10","doi-asserted-by":"publisher","first-page":"9S","DOI":"10.1378\/chest.116.suppl_1.9S-a","volume":"116","author":"AS Slutsky","year":"1999","unstructured":"Slutsky, A. S. Lung injury caused by mechanical ventilation. Chest 116, 9S-15S (1999).","journal-title":"Chest"},{"key":"19560_CR11","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1164\/arrd.1974.110.5.556","volume":"110","author":"HH Webb","year":"1974","unstructured":"Webb, H. H. & Tierney, D. F. Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures. Protection by positive end-expiratory pressure. Am. Rev. Respir. Dis. 110, 556\u2013565. https:\/\/doi.org\/10.1164\/arrd.1974.110.5.556 (1974).","journal-title":"Am. Rev. Respir. Dis."},{"key":"19560_CR12","doi-asserted-by":"publisher","unstructured":"Acute Respiratory Distress Syndrome, N. et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N. Engl. J. Med. 342, 1301-1308, doi:https:\/\/doi.org\/10.1056\/NEJM200005043421801 (2000).","DOI":"10.1056\/NEJM200005043421801"},{"key":"19560_CR13","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1001\/jama.2012.13730","volume":"308","author":"A Serpa Neto","year":"2012","unstructured":"Serpa Neto, A. et al. Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA 308, 1651\u20131659. https:\/\/doi.org\/10.1001\/jama.2012.13730 (2012).","journal-title":"JAMA"},{"key":"19560_CR14","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1186\/cc7688","volume":"13","author":"EK Wolthuis","year":"2009","unstructured":"Wolthuis, E. K. et al. Mechanical ventilation using non-injurious ventilation settings causes lung injury in the absence of pre-existing lung injury in healthy mice. Crit. Care 13, R1. https:\/\/doi.org\/10.1186\/cc7688 (2009).","journal-title":"Crit. Care"},{"key":"19560_CR15","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/ALN.0b013e3181b764d2","volume":"111","author":"PP Terragni","year":"2009","unstructured":"Terragni, P. P. et al. Tidal volume lower than 6 ml\/kg enhances lung protection: Role of extracorporeal carbon dioxide removal. Anesthesiology 111, 826\u2013835. https:\/\/doi.org\/10.1097\/ALN.0b013e3181b764d2 (2009).","journal-title":"Anesthesiology"},{"key":"19560_CR16","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0092-8674(00)81813-9","volume":"87","author":"C Suri","year":"1996","unstructured":"Suri, C. et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171\u20131180 (1996).","journal-title":"Cell"},{"key":"19560_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1126\/science.277.5322.55","volume":"277","author":"PC Maisonpierre","year":"1997","unstructured":"Maisonpierre, P. C. et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55\u201360 (1997).","journal-title":"Science"},{"key":"19560_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.devcel.2007.10.019","volume":"14","author":"J Gavard","year":"2008","unstructured":"Gavard, J., Patel, V. & Gutkind, J. S. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev. Cell 14, 25\u201336. https:\/\/doi.org\/10.1016\/j.devcel.2007.10.019 (2008).","journal-title":"Dev. Cell"},{"key":"19560_CR19","doi-asserted-by":"publisher","first-page":"23910","DOI":"10.1074\/jbc.M702169200","volume":"282","author":"T Mammoto","year":"2007","unstructured":"Mammoto, T. et al. Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo. J. Biol. Chem. 282, 23910\u201323918. https:\/\/doi.org\/10.1074\/jbc.M702169200 (2007).","journal-title":"J. Biol. Chem."},{"key":"19560_CR20","doi-asserted-by":"publisher","first-page":"e70459","DOI":"10.1371\/journal.pone.0070459","volume":"8","author":"AV Benest","year":"2013","unstructured":"Benest, A. V. et al. Angiopoietin-2 is critical for cytokine-induced vascular leakage. PLoS ONE 8, e70459. https:\/\/doi.org\/10.1371\/journal.pone.0070459 (2013).","journal-title":"PLoS ONE"},{"key":"19560_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nm1351","volume":"12","author":"U Fiedler","year":"2006","unstructured":"Fiedler, U. et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat. Med. 12, 235\u2013239. https:\/\/doi.org\/10.1038\/nm1351 (2006).","journal-title":"Nat. Med."},{"key":"19560_CR22","doi-asserted-by":"publisher","first-page":"L851","DOI":"10.1152\/ajplung.00459.2010","volume":"300","author":"S David","year":"2011","unstructured":"David, S. et al. Effects of a synthetic PEG-ylated Tie-2 agonist peptide on endotoxemic lung injury and mortality. Am. J. Physiol. Lung Cell Mol. Physiol. 300, L851-862. https:\/\/doi.org\/10.1152\/ajplung.00459.2010 (2011).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"19560_CR23","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1164\/rccm.201708-1733OC","volume":"198","author":"B Gutbier","year":"2018","unstructured":"Gutbier, B. et al. Prognostic and pathogenic role of angiopoietin-1 and -2 in pneumonia. Am. J. Respir. Crit. Care Med. 198, 220\u2013231. https:\/\/doi.org\/10.1164\/rccm.201708-1733OC (2018).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"19560_CR24","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1371\/journal.pmed.0030046","volume":"3","author":"SM Parikh","year":"2006","unstructured":"Parikh, S. M. et al. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med. 3, e46. https:\/\/doi.org\/10.1371\/journal.pmed.0030046 (2006).","journal-title":"PLoS Med."},{"key":"19560_CR25","doi-asserted-by":"publisher","first-page":"R91","DOI":"10.1186\/cc9025","volume":"14","author":"LA Mankhambo","year":"2010","unstructured":"Mankhambo, L. A. et al. The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children. Crit. Care 14, R91. https:\/\/doi.org\/10.1186\/cc9025 (2010).","journal-title":"Crit. Care"},{"key":"19560_CR26","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/SHK.0b013e318188bd06","volume":"31","author":"JM Siner","year":"2009","unstructured":"Siner, J. M., Bhandari, V., Engle, K. M., Elias, J. A. & Siegel, M. D. Elevated serum angiopoietin 2 levels are associated with increased mortality in sepsis. Shock 31, 348\u2013353. https:\/\/doi.org\/10.1097\/SHK.0b013e318188bd06 (2009).","journal-title":"Shock"},{"key":"19560_CR27","doi-asserted-by":"publisher","first-page":"R147","DOI":"10.1186\/cc7130","volume":"12","author":"P Kumpers","year":"2008","unstructured":"Kumpers, P. et al. Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit. Care 12, R147. https:\/\/doi.org\/10.1186\/cc7130 (2008).","journal-title":"Crit. Care"},{"key":"19560_CR28","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/CCM.0b013e318206d285","volume":"39","author":"DR Ricciuto","year":"2011","unstructured":"Ricciuto, D. R. et al. Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit. Care Med. 39, 702\u2013710. https:\/\/doi.org\/10.1097\/CCM.0b013e318206d285 (2011).","journal-title":"Crit. Care Med."},{"key":"19560_CR29","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1089\/ten.tea.2007.0400","volume":"15","author":"P Van Slyke","year":"2009","unstructured":"Van Slyke, P. et al. Acceleration of diabetic wound healing by an angiopoietin peptide mimetic. Tissue Eng. Part A 15, 1269\u20131280. https:\/\/doi.org\/10.1089\/ten.tea.2007.0400 (2009).","journal-title":"Tissue Eng. Part A"},{"key":"19560_CR30","doi-asserted-by":"publisher","first-page":"R261","DOI":"10.1186\/cc10523","volume":"15","author":"P Kumpers","year":"2011","unstructured":"Kumpers, P. et al. The synthetic tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis. Crit. Care 15, R261. https:\/\/doi.org\/10.1186\/cc10523 (2011).","journal-title":"Crit. Care"},{"key":"19560_CR31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/ALN.0000000000001907","volume":"128","author":"M Trieu","year":"2018","unstructured":"Trieu, M. et al. Vasculotide, an angiopoietin-1 mimetic, restores microcirculatory perfusion and microvascular leakage and decreases fluid resuscitation requirements in hemorrhagic shock. Anesthesiology 128, 361\u2013374. https:\/\/doi.org\/10.1097\/ALN.0000000000001907 (2018).","journal-title":"Anesthesiology"},{"key":"19560_CR32","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.bja.2018.05.049","volume":"121","author":"NAM Dekker","year":"2018","unstructured":"Dekker, N. A. M. et al. Vasculotide, an angiopoietin-1 mimetic, reduces pulmonary vascular leakage and preserves microcirculatory perfusion during cardiopulmonary bypass in rats. Br. J. Anaesth. 121, 1041\u20131051. https:\/\/doi.org\/10.1016\/j.bja.2018.05.049 (2018).","journal-title":"Br. J. Anaesth."},{"key":"19560_CR33","doi-asserted-by":"publisher","first-page":"11030","DOI":"10.1038\/srep11030","volume":"5","author":"MG Sugiyama","year":"2015","unstructured":"Sugiyama, M. G. et al. The Tie2-agonist vasculotide rescues mice from influenza virus infection. Sci. Rep. 5, 11030. https:\/\/doi.org\/10.1038\/srep11030 (2015).","journal-title":"Sci. Rep."},{"key":"19560_CR34","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13054-017-1851-6","volume":"21","author":"B Gutbier","year":"2017","unstructured":"Gutbier, B. et al. Vasculotide reduces pulmonary hyperpermeability in experimental pneumococcal pneumonia. Crit. Care 21, 274. https:\/\/doi.org\/10.1186\/s13054-017-1851-6 (2017).","journal-title":"Crit. Care"},{"key":"19560_CR35","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1186\/cc9209","volume":"14","author":"HC Muller","year":"2010","unstructured":"Muller, H. C. et al. Simvastatin attenuates ventilator-induced lung injury in mice. Crit. Care 14, R143. https:\/\/doi.org\/10.1186\/cc9209 (2010).","journal-title":"Crit. Care"},{"key":"19560_CR36","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1186\/cc13830","volume":"18","author":"HC Muller-Redetzky","year":"2014","unstructured":"Muller-Redetzky, H. C. et al. Mechanical ventilation drives pneumococcal pneumonia into lung injury and sepsis in mice: Protection by adrenomedullin. Crit. Care 18, R73. https:\/\/doi.org\/10.1186\/cc13830 (2014).","journal-title":"Crit. Care"},{"key":"19560_CR37","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.1128\/Iai.00948-15","volume":"83","author":"K Reppe","year":"2015","unstructured":"Reppe, K. et al. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection. Infect. Immun. 83, 4617\u20134629. https:\/\/doi.org\/10.1128\/Iai.00948-15 (2015).","journal-title":"Infect. Immun."},{"key":"19560_CR38","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1165\/rcmb.2014-0052MA","volume":"51","author":"C Dames","year":"2014","unstructured":"Dames, C. et al. Miniaturized bronchoscopy enables unilateral investigation, application, and sampling in mice. Am. J. Respir. Cell Mol. 51, 730\u2013737. https:\/\/doi.org\/10.1165\/rcmb.2014-0052MA (2014).","journal-title":"Am. J. Respir. Cell Mol."},{"key":"19560_CR39","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/ALN.0000000000003149","volume":"132","author":"H Muller-Redetzky","year":"2020","unstructured":"Muller-Redetzky, H. et al. Neutralizing complement c5a protects mice with pneumococcal pulmonary sepsis. Anesthesiology 132, 795\u2013807. https:\/\/doi.org\/10.1097\/ALN.0000000000003149 (2020).","journal-title":"Anesthesiology"},{"key":"19560_CR40","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13054-018-2224-5","volume":"22","author":"S Berger","year":"2018","unstructured":"Berger, S. et al. Delay in antibiotic therapy results in fatal disease outcome in murine pneumococcal pneumonia. Crit. Care 22, 287. https:\/\/doi.org\/10.1186\/s13054-018-2224-5 (2018).","journal-title":"Crit. Care"},{"key":"19560_CR41","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1183\/16000617.0034-2015","volume":"24","author":"H Muller-Redetzky","year":"2015","unstructured":"Muller-Redetzky, H., Lienau, J., Suttorp, N. & Witzenrath, M. Therapeutic strategies in pneumonia: Going beyond antibiotics. Eur. Respir. Rev. 24, 516\u2013524. https:\/\/doi.org\/10.1183\/16000617.0034-2015 (2015).","journal-title":"Eur. Respir. Rev."},{"key":"19560_CR42","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00441-014-1821-0","volume":"355","author":"HC Muller-Redetzky","year":"2014","unstructured":"Muller-Redetzky, H. C., Suttorp, N. & Witzenrath, M. Dynamics of pulmonary endothelial barrier function in acute inflammation: Mechanisms and therapeutic perspectives. Cell Tissue Res. 355, 657\u2013673. https:\/\/doi.org\/10.1007\/s00441-014-1821-0 (2014).","journal-title":"Cell Tissue Res."},{"key":"19560_CR43","doi-asserted-by":"publisher","first-page":"22111","DOI":"10.1038\/srep22111","volume":"6","author":"E Rubig","year":"2016","unstructured":"Rubig, E. et al. The synthetic tie2 agonist peptide vasculotide protects renal vascular barrier function in experimental acute kidney injury. Sci. Rep. 6, 22111. https:\/\/doi.org\/10.1038\/srep22111 (2016).","journal-title":"Sci. Rep."},{"key":"19560_CR44","doi-asserted-by":"publisher","first-page":"573","DOI":"10.5500\/wjt.v6.i3.573","volume":"6","author":"K Thamm","year":"2016","unstructured":"Thamm, K. et al. Pharmacological Tie2 activation in kidney transplantation. World J. Transplant. 6, 573\u2013582. https:\/\/doi.org\/10.5500\/wjt.v6.i3.573 (2016).","journal-title":"World J. Transplant."},{"key":"19560_CR45","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1177\/0963689718791568","volume":"27","author":"P Venkat","year":"2018","unstructured":"Venkat, P. et al. Angiopoietin-1 mimetic peptide promotes neuroprotection after stroke in type 1 diabetic rats. Cell Transplant. 27, 1744\u20131752. https:\/\/doi.org\/10.1177\/0963689718791568 (2018).","journal-title":"Cell Transplant."},{"key":"19560_CR46","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/sj.embor.7400100","volume":"5","author":"R Tournaire","year":"2004","unstructured":"Tournaire, R. et al. A short synthetic peptide inhibits signal transduction, migration and angiogenesis mediated by Tie2 receptor. EMBO Rep. 5, 262\u2013267. https:\/\/doi.org\/10.1038\/sj.embor.7400100 (2004).","journal-title":"EMBO Rep."},{"key":"19560_CR47","doi-asserted-by":"publisher","first-page":"770","DOI":"10.15252\/emmm.201404193","volume":"7","author":"FT Wu","year":"2015","unstructured":"Wu, F. T. et al. Vasculotide reduces endothelial permeability and tumor cell extravasation in the absence of binding to or agonistic activation of Tie2. EMBO Mol. Med. 7, 770\u2013787. https:\/\/doi.org\/10.15252\/emmm.201404193 (2015).","journal-title":"EMBO Mol. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19560-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19560-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19560-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T17:07:42Z","timestamp":1663261662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19560-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,15]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["19560"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-19560-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,15]]},"assertion":[{"value":"8 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Steven Chackowicz, Doug Hamilton and Paul Van Slyke are named as inventors on several patents related to the Vasculotide technology. Doug Hamilton and Steven Chackowicz are officers in Vasomune Therapeutics. All other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15531"}}